Secondary Necrotic Neutrophils Release Interleukin-16C and Macrophage Migration Inhibitory Factor from Stores in the Cytosol
Overview
Affiliations
Neutrophils harbor a number of preformed effector proteins that allow for immediate antimicrobial functions without the need for time-consuming de novo synthesis. Evidence indicates that neutrophils also contain preformed cytokines, including interleukin (IL)-1ra, CXCL8 and CXCL2. In the search for additional preformed cytokines, a cytokine array analysis identified IL-16 and macrophage migration inhibitory factor (MIF) as preformed cytokines in lysates from human primary neutrophils. Both IL-16 and MIF are unconventional cytokines because they lack a signal sequence. Using confocal immunofluorescence microscopy as well as western blot analysis of subcellular fractions, IL-16 and MIF were found to be stored in the cytosol rather than in the granules of human neutrophils, which implies an unconventional secretion mechanism for both cytokines. IL-16 is synthesized and stored as a precursor (pre-IL-16). We present evidence that the processing of pre-IL-16 to the biologically active IL-16C is mediated by caspase-3 and occurs during both spontaneous and UV-induced apoptosis of human neutrophils. Although IL-16 processing occurs during apoptosis, IL-16C and MIF release was observed only during secondary necrosis of neutrophils. Screening a panel of microbial substances and proinflammatory cytokines did not identify a stimulus that induced the release of IL-16C and MIF independent of secondary necrosis. The data presented here suggest that IL-16 and MIF are neutrophil-derived inflammatory mediators released under conditions of insufficient clearance of apoptotic neutrophils, as typically occurs at sites of infection and autoimmunity.
Michels E, Chouchane O, de Brabander J, de Vos A, Faber D, Douma R Front Immunol. 2024; 15:1470383.
PMID: 39493755 PMC: 11527607. DOI: 10.3389/fimmu.2024.1470383.
Hyperalgesic Effect Evoked by il-16 and its Participation in Inflammatory Hypernociception in Mice.
Gonzalez-Rodriguez S, Sordo-Bahamonde C, Alvarez-Artime A, Baamonde A, Menendez L J Neuroimmune Pharmacol. 2024; 19(1):44.
PMID: 39152360 PMC: 11329551. DOI: 10.1007/s11481-024-10145-7.
Interleukin-16 is increased in dialysis patients but is not a cardiovascular risk factor.
Brosecke F, Pfau A, Ermer T, Dein Terra Mota Ribeiro A, Rubenbauer L, Rao V Sci Rep. 2024; 14(1):11323.
PMID: 38760468 PMC: 11101424. DOI: 10.1038/s41598-024-61808-7.
Fava A, Buyon J, Magder L, Hodgin J, Rosenberg A, Demeke D JCI Insight. 2024; 9(2.
PMID: 38258904 PMC: 10906224. DOI: 10.1172/jci.insight.172569.
Lupus Nephritis Biomarkers: A Critical Review.
Alduraibi F, Tsokos G Int J Mol Sci. 2024; 25(2).
PMID: 38255879 PMC: 10815779. DOI: 10.3390/ijms25020805.